Rad Source Launches AccuTag™ Blood Irradiation Indicators Ahead of AABB 2026

Skip to Content News Archives Economy Defence Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Defence Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Defence Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Rad Source Launches AccuTag™ Blood Irradiation Indicators Ahead of AABB 2026Author of the article:AccuTag indicators are applied to the blood bag, blood product or syringe before irradiation. The central dot starts out white and turns blue after x-ray or gamma irradiation, giving staff a quick visual check that the product was irradiated. GNWWhite-to-blue indicator gives blood banks visual confirmation of the 15 Gy minimum at a 25 Gy target dose, on display at Booth 1314THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountBUFORD, Ga., Oct. 14, 2026 (GLOBE NEWSWIRE) — Rad Source Technologies, Inc. (Rad Source®), the global leader in biological x-ray solutions for life sciences, today announced the launch of AccuTag™ blood irradiation indicators, which it will showcase at the AABB 2026 Annual Meeting, Oct. 17 to 19 at the Georgia World Congress Center in Atlanta. Designed for blood banks, transfusion services and hospital irradiation programs, AccuTag gives clinical staff a quick, visual way to confirm that a minimum of 15 Gy has been delivered when blood is irradiated to a 25 Gy target.This advertisement has not loaded yet, but your article continues below.FDA recommendations specify a minimum dose of 15 Gy and a target dose of 25 Gy to help prevent transfusion-associated graft-versus-host disease (TA-GVHD). AccuTag is a radiochromic indicator label that changes from white to blue to indicate that a blood product received at least 15 Gy, and it was built to support that standard.Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againSimple by Design: White to BlueStaff attach AccuTag to the blood bag, blood product or syringe before irradiation. The central dot starts out white and turns blue after exposure to x-ray or gamma irradiation. After irradiation, staff check that the center dot is as dark as or darker than the light blue reference color. There are no extra steps and no extra equipment.Built to Confirm Dose DeliveryAccuTag’s radiochromic central dot is engineered to indicate a minimum of 15 Gy at a 25 Gy target dose, aligning with FDA recommendations and facility protocols.That design is the subject of a poster Rad Source is presenting at AABB 2026. Researchers irradiated AccuTag and two other commercially available 15 Gy blood irradiation indicators in a calibrated RS® 3400 x-ray blood irradiator at 10, 15, 25, 50 and 75 Gy, plus an unirradiated (0 Gy) control, with each indicator placed in the central region of a blood phantom. AccuTag exhibited a progressive, dose-dependent visual response across the evaluated dose range, with color changes distinguishable between under-irradiation (10 Gy), the FDA-recommended dose range (15 Gy minimum and 25 Gy target) and higher-dose conditions (50 to 75 Gy). The other two indicators confirmed irradiation exposure but did not provide distinguishable dose-level verification, consistent with their intended design and labeling.This advertisement has not loaded yet, but your article continues below.AccuTag is a semi-quantitative indicator. It shows that irradiation occurred at the intended level but is not a precise dosimeter, and regular maintenance of the irradiator is recommended to ensure consistent results.“Many indicators are designed only to indicate exposure, not to verify a specific delivered dose. In our evaluation, AccuTag showed a progressive visual response from the 15 Gy minimum through the 25 Gy target, in line with FDA recommendations, so staff can see at a glance whether a product has reached the intended dose range,” said Justin Czerniawski, PhD, Vice President of Research & Development at Rad Source Technologies.“AccuTag’s white-to-blue dot gives clinical teams visible confirmation at the point of care, and the data we are presenting at AABB shows why that matters. Paired with the RS 3400, it gives transfusion services a more complete irradiation workflow,” said George Terry, Executive Vice President of Sales & Marketing at Rad Source Technologies.Visit Rad Source at Booth 1314 to see AccuTag and order samples. Rad Source will also present the poster “Evaluation of blood irradiation indicators for dose verification and FDA recommendation compliance” at the AABB Meet the Poster Author session on Sunday, Oct. 18, from noon to 1 p.m. ET. Authored by Justin Czerniawski, PhD, of Rad Source Technologies, the study evaluated indicator response across clinically relevant doses against FDA recommendations and the AABB Standards for Blood Banks and Transfusion Services (35th ed.).This advertisement has not loaded yet.This advertisement has not loaded yet, but your article continues below.Learn more about AccuTag blood irradiation indicators at https://info.radsource.com/accutag Rad Source Technologies, Inc. is the global leader in biological x-ray solutions for life sciences. Its portfolio includes the RS® 3400 Blood Irradiator, the RS® 2400 Sterile Insect Irradiator, the RS® 2000 Biological Irradiator and the QUASTAR® x-ray technology platform.SOURCE: Rad Source Technologies, Inc.Rad Source®, RS®, QUASTAR® and AccuTag™ are trademarks or registered trademarks of Rad Source Technologies, Inc.Photos accompanying this announcement are available at Media Contact: Nicole Bailey Phone: 678-765-7900 Email: nbailey@radsource.comThis advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.